 2016-2017 Tribal and Inactivated Influenza Vaccine, TIV, had a moderate effectiveness of 69% against laboratory-confirmed influenza illness among school children in Beijing, China during the 2016-2017 influenza season. This article was authored by Li Zhong, Vim Van Der Hoek, Thomas Kraft, and others.